Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Role of substance P in PTH secretion described

Nov. 24, 1997

GH secretagogues under development at Merck & Co.

Nov. 24, 1997

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Nov. 24, 1997

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Novel agent for insulin resistance, S-15261, evaluated in rat model

Nov. 21, 1997

Spotlight on selective estrogen receptor modulators

Nov. 21, 1997

Torii reveals antidiabetic thiazolidinediones

Nov. 21, 1997

Japanese researchers develop new animal model of obesity

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...